INFLIXIMAB (IFX) DOES NOT INCREASE THE RISK OF CYTOMEGALOVIRUS (CMV) INFECTION AND CMV IS NOT ASSOCIATED TO RESISTANCE TO IFX THERAPY

Sylvie Pillet  1     Emile Del Tedesco  1     mathilde courault  1     emilie presles  1     amelie moreau  1     Bruno Pozzetto  1     Xavier Roblin  1    
1 UNIVERSITY

Session
IBD II

Conference
UEG Week 2013

Citation
United European Gastroenterology Journal; 2013: 1 (Supplement 1) A368


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing